Watchlist Price Alert

KalVista Pharmaceuticals ... (KALV)

NASDAQ: KALV · Real-Time Price · USD

11.39

-0.08 (-0.70%)

At close: May 27, 2025, 3:17 PM

KalVista Pharmaceuticals Income Statement

Financials in USD. Fiscal year is May - April.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020	Apr 30, 2019	Apr 30, 2018	Apr 30, 2017	Apr 30, 2016
Revenue	n/a	n/a	n/a	12.69M	12.69M	16.13M	8.39M	1.5M	2.13M
Cost of Revenue	86.17M	802K	743K	651K	40.19K	35.02K	18.24K	12.67K	14.66K
Gross Profit	-86.17M	-802K	-743K	12.04M	12.65M	16.09M	8.38M	1.49M	2.12M
Operating Income	-140.44M	-110.87M	-96.61M	-57.92M	-40.53M	-29.82M	-18.7M	-22.34M	-15.18M
Interest Income	n/a	2.23M	1.09M	903K	1.83M	1.4M	82K	36K	50K
Pretax Income	-135.1M	-92.91M	-82.34M	-46.24M	-29.24M	-20.69M	-15.8M	-18.6M	-11.44M
Net Income	-126.64M	-74.85M	-68.51M	-44.49M	-29.12M	-20.82M	-15.8M	-18.6M	-11.44M
Selling & General & Admin	54.28M	30.59M	26.45M	16.64M	13.03M	10.93M	8.86M	11.18M	2.65M
Research & Development	86.17M	80.28M	70.17M	41.29M	40.19M	35.02M	18.24M	12.67M	14.66M
Other Expenses	-86.17M	15.64M	14.72M	9.93M	9.83M	7.68M	4.39M	2.33M	2.03M
Operating Expenses	54.28M	110.87M	96.61M	57.92M	53.22M	45.95M	27.1M	23.84M	17.31M
Interest Expense	n/a	n/a	1.09M	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	140.44M	110.87M	96.61M	57.92M	53.22M	45.95M	27.1M	23.84M	17.31M
Income Tax Expense	-8.45M	-18.05M	-13.83M	-1.75M	-124K	124K	-1.33M	-5.11M	-5.41M
Shares Outstanding (Basic)	36.79M	27.89M	24.47M	19.09M	17.75M	15.08M	10.32M	9.71M	4.77M
Shares Outstanding (Diluted)	36.79M	27.89M	24.47M	19.09M	17.75M	15.08M	10.32M	9.71M	4.77M
EPS (Basic)	-3.44	-2.68	-2.8	-2.33	-1.64	-1.38	-1.53	-1.92	-2.4
EPS (Diluted)	-3.44	-2.68	-2.8	-2.33	-1.64	-1.38	-1.53	-1.92	-2.4
EBITDA	-134.28M	-92.11M	-81.6M	-45.59M	-40.02M	-29.44M	-18.52M	-22.3M	-15.15M
EBIT	-135.1M	-110.87M	-96.61M	-57.92M	-40.53M	-29.82M	-18.7M	-22.34M	-15.18M
Depreciation & Amortization	816K	802K	743K	651K	525K	378K	180K	40K	133K